NEOGENOMICS INC 4
4 · NEOGENOMICS INC · Filed Mar 28, 2017
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Exercise of In-Money
Common Stock
2017-03-27$3.76/sh+10,000$37,600→ 25,953 total - Exercise of In-Money
Stock Option
2017-03-27$3.76/sh−10,000$37,600→ 0 totalExercise: $3.76From: 2014-04-16Exp: 2018-04-16→ Common Stock (10,000 underlying)
Holdings
- 120,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying) - 100,000
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]On March 5, 2014 Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
- [F2]On May 4, 2015 Dr, Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F3]On April 20, 2016, Mr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.